| Authors: |
Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts., Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts., Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts., Cunningham JW; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts., Pabon MA; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts., Lam CSP; National Heart Centre Singapore & Duke-National University of Singapore, Singapore., Senni M; University of Milano-Bicocca, Papa Giovanni XXIII Hospital, Bergamo, Italy., Shah S; Northwestern University Feinberg School of Medicine, Chicago, Illinois., Voors AA; University of Groningen, Groningen, Netherlands., Zannad F; University of Lorraine, Nancy, France., Pitt B; University of Michigan, Ann Arbor., Amarante F; Bayer, Cardiology and Nephrology Clinical Development, Bayer SA, São Paulo, Brazil., Lay-Flurrie J; Bayer plc, Research & Development, Pharmaceuticals, Reading, United Kingdom., Scheerer MF; Bayer AG, Global Medical Affairs, Berlin, Germany., Lage A; Bayer, Cardiology and Nephrology Clinical Development, Bayer SA, São Paulo, Brazil., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts. |
